Biohaven Ltd (NYSE: BHVN) on Monday, soared 10.37% from the previous trading day, before settling in for the closing price of $9.55. Within the past 52 weeks, BHVN’s price has moved between $7.48 and $45.87.
During the last 5-year period, the sales drop of Healthcare Sector giant was -49.78%. The company achieved an average annual earnings per share of 28.24%. With a float of $108.12 million, this company’s outstanding shares have now reached $129.19 million.
Biohaven Ltd (BHVN) Insider Activity
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Biohaven Ltd is 16.31%, while institutional ownership is 67.18%. The most recent insider transaction that took place on Nov 17 ’25, was worth 144,770. In this transaction VP, Chief Accounting Officer of this company bought 17,000 shares at a rate of $8.52, taking the stock ownership to the 20,000 shares. Before that another transaction happened on Nov 13 ’25, when Company’s Director bought 400,000 for $7.50, making the entire transaction worth $3,000,000. This insider now owns 2,020,071 shares in total.
Biohaven Ltd (BHVN) Earnings and Forecasts
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported -1.71 earnings per share (EPS) for the period falling under the consensus outlook (set at -1.47) by -0.24. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.96 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 28.24% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 37.82% during the next five years compared to -49.78% drop over the previous five years of trading.
Biohaven Ltd (NYSE: BHVN) Trading Performance Indicators
Biohaven Ltd (BHVN) is currently performing well based on its current performance indicators. A quick ratio of 2.86 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -7.60, a number that is poised to hit -1.23 in the next quarter and is forecasted to reach -3.21 in one year’s time.
Technical Analysis of Biohaven Ltd (BHVN)
Looking closely at Biohaven Ltd (NYSE: BHVN), its last 5-days average volume was 3.19 million, which is a jump from its year-to-date volume of 2.27 million. As of the previous 9 days, the stock’s Stochastic %D was 75.62%.
During the past 100 days, Biohaven Ltd’s (BHVN) raw stochastic average was set at 27.60%, which indicates a significant decrease from 90.59% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.76 in the past 14 days, which was lower than the 0.95 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $12.91, while its 200-day Moving Average is $17.24. However, in the short run, Biohaven Ltd’s stock first resistance to watch stands at $10.98. Second resistance stands at $11.42. The third major resistance level sits at $12.06. If the price goes on to break the first support level at $9.90, it is likely to go to the next support level at $9.26. Should the price break the second support level, the third support level stands at $8.82.
Biohaven Ltd (NYSE: BHVN) Key Stats
Market capitalization of the company is 1.36 billion based on 105,855K outstanding shares. Right now, sales total 0 K and income totals -846,420 K. The company made 0 K in profit during its latest quarter, and -173,440 K in sales during its previous quarter.
